These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1587 related items for PubMed ID: 8644702

  • 1. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
    Johannsson O, Ostermeyer EA, Håkansson S, Friedman LS, Johansson U, Sellberg G, Brøndum-Nielsen K, Sele V, Olsson H, King MC, Borg A.
    Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
    Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ.
    Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
    [Abstract] [Full Text] [Related]

  • 4. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.
    Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK.
    Am J Hum Genet; 1996 Jun; 58(6):1166-76. PubMed ID: 8651293
    [Abstract] [Full Text] [Related]

  • 5. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjäkoski K, Pyrhönen S, Kallioniemi OP, Muhonen T, Luce M, Frank TS, Nevanlinna H.
    Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
    [Abstract] [Full Text] [Related]

  • 6. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
    Serova O, Montagna M, Torchard D, Narod SA, Tonin P, Sylla B, Lynch HT, Feunteun J, Lenoir GM.
    Am J Hum Genet; 1996 Jan; 58(1):42-51. PubMed ID: 8554067
    [Abstract] [Full Text] [Related]

  • 7. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
    Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, Dann JL, King MC.
    Am J Hum Genet; 1997 May; 60(5):1031-40. PubMed ID: 9150150
    [Abstract] [Full Text] [Related]

  • 8. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.
    Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC.
    Nat Genet; 1994 Dec; 8(4):399-404. PubMed ID: 7894493
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
    Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S.
    Int J Cancer; 2001 Jan 01; 91(1):83-8. PubMed ID: 11149425
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
    Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J.
    Am J Hum Genet; 2000 Jun 01; 66(6):1963-8. PubMed ID: 10788334
    [Abstract] [Full Text] [Related]

  • 13. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL.
    J Clin Oncol; 2001 Apr 15; 19(8):2247-53. PubMed ID: 11304778
    [Abstract] [Full Text] [Related]

  • 14. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
    Santarosa M, Dolcetti R, Magri MD, Crivellari D, Tibiletti MG, Gallo A, Tumolo S, Della Puppa L, Furlan D, Boiocchi M, Viel A.
    Int J Cancer; 1999 Sep 24; 83(1):5-9. PubMed ID: 10449599
    [Abstract] [Full Text] [Related]

  • 15. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.
    Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc JF, Bélanger C, Dion F.
    Nat Genet; 1994 Dec 24; 8(4):392-8. PubMed ID: 7894492
    [Abstract] [Full Text] [Related]

  • 16. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
    Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.
    Am J Hum Genet; 2000 Apr 24; 66(4):1259-72. PubMed ID: 10739756
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
    Rebbeck TR, Couch FJ, Kant J, Calzone K, DeShano M, Peng Y, Chen K, Garber JE, Weber BL.
    Am J Hum Genet; 1996 Sep 24; 59(3):547-53. PubMed ID: 8751855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.